TrialHIV medicine2016

The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir.

D A Wohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.